About Voyager Biomedical
Voyager Biomedical is a private company based in Houston, Texas. It has reported $6,794,417 raised in two offerings on Form D since October 2020. Its chief executive is Marcus Penna.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 21, 2025 | Apr 4, 2025 | $5,799,417of $9.7M target | 18 | $322K | EquityRule 506(b) | Form D ↗ |
| Feb 19, 2019 | Oct 22, 2020 | $995,000target not set | 15 | $66,333 | Debt, OptionsRule 506(b) | Form D ↗ |
| Total, two offerings | $6,794,417 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Voyager Biomedical's Form D filed Apr 4, 2025.
MP
Marcus Penna
Chief Executive Officer and director
MK
Monica Klos
Executive officer
AG
Ashok Gowda
Director
BS
Bruce Shook
Director
TU
Trevor Uhl
Director
AG
Alan Glowczwski
Director
Earlier filings also listed Robert Smith (promoter, last listed Oct 2020), Peter Smith (promoter, last listed Oct 2020), Nathan Borgfeld (promoter, last listed Oct 2020), Linda Spain (executive officer and director, last listed Oct 2020) and April Lovelady (promoter, last listed Oct 2020).